Skip to main content
Premium Trial:

Request an Annual Quote

Cell Biosciences Places Protein Analysis Prototype at Stanford

NEW YORK (GenomeWeb News) – Palo Alto, Calif.-based nanoproteomics company Cell Biosciences announced today that it has placed a prototype of a next-generation protein analysis system at Stanford University’s School of Medicine.
 
The company said that David Hirschberg, director of Stanford’s Human Immune Monitoring Center, will use Cell Biosciences’ CB1000 system for analyzing human clinical samples and will provide feedback aimed at improving product design and optimizing system features.
 
The CB1000 is a nanofluidic immunoassay system developed for the sensitive analysis of small biological samples. Compared with earlier systems, the new prototype is designed to have a more streamlined workflow, smaller footprint, and improved performance. It can reportedly measure signaling proteins reproducibly using as few as 25 cells.
 
The system is scheduled for commercial release in mid-2009.
 

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.